ClinVar Genomic variation as it relates to human health
NM_004700.4(KCNQ4):c.961G>A (p.Gly321Ser)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_004700.4(KCNQ4):c.961G>A (p.Gly321Ser)
Variation ID: 6243 Accession: VCV000006243.13
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 1p34.2 1: 40820180 (GRCh38) [ NCBI UCSC ] 1: 41285852 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Oct 2, 2016 Apr 20, 2024 Apr 11, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_004700.4:c.961G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_004691.2:p.Gly321Ser missense NM_004700.3:c.961G>A NM_172163.3:c.961G>A NP_751895.1:p.Gly321Ser missense NC_000001.11:g.40820180G>A NC_000001.10:g.41285852G>A NG_008139.3:g.41394G>A LRG_1378:g.41394G>A LRG_1378t1:c.961G>A LRG_1378p1:p.Gly321Ser P56696:p.Gly321Ser - Protein change
- G321S
- Other names
- -
- Canonical SPDI
- NC_000001.11:40820179:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD) 0.00001
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
KCNQ4 | - | - |
GRCh38 GRCh37 |
380 | 400 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Likely pathogenic (4) |
criteria provided, single submitter
|
Apr 11, 2023 | RCV000006621.8 | |
Likely pathogenic (1) |
criteria provided, single submitter
|
Oct 14, 2020 | RCV001195307.5 | |
Pathogenic/Likely pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Dec 1, 2022 | RCV002512842.4 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Jan 05, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV003522655.2
First in ClinVar: Feb 07, 2023 Last updated: Feb 14, 2024 |
Comment:
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has … (more)
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this missense change affects KCNQ4 function (PMID: 20966080, 23750663, 26515070). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNQ4 protein function. ClinVar contains an entry for this variant (Variation ID: 6243). This missense change has been observed in individuals with autosomal dominant deafness (PMID: 10369879; Invitae). This variant is present in population databases (rs28939710, gnomAD 0.007%). This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 321 of the KCNQ4 protein (p.Gly321Ser). (less)
|
|
Likely Pathogenic
(Oct 14, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Rare genetic deafness
(Autosomal dominant inheritance)
Affected status: unknown
Allele origin:
germline
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Accession: SCV001365632.2
First in ClinVar: Jul 04, 2020 Last updated: Apr 20, 2024 |
Comment:
The p.Gly321Ser variant in KCNQ4 has been previously reported to segregate with autosomal dominant hearing loss in multiple individuals from a large Dutch family (Coucke … (more)
The p.Gly321Ser variant in KCNQ4 has been previously reported to segregate with autosomal dominant hearing loss in multiple individuals from a large Dutch family (Coucke 1999 PMID: 10369879, Van Camp 1997 PMID: 9126484). It has also been identified in 0.006% (1/15414) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org) and is present in ClinVar (Variation ID 6243). Functional studies indicate that the variant results in a dominant negative effect (Leitner 2012 PMID: 21951272, Gao 2013 PMID: 23750663), and computational tools and conservation analyses also suggest an impact to the protein. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal dominant hearing loss. ACMG/AMP Criteria applied: PP1_Moderate, PM2, PP3, PS3_Supporting. (less)
|
|
Pathogenic
(Dec 01, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV003931052.1
First in ClinVar: Jun 17, 2023 Last updated: Jun 17, 2023 |
Comment:
Published functional studies demonstrate p.(G321S) results in non-functional channels and significantly reduces KCNQ4 trafficking (Kim et al., 2011; Gao et al., 2013); Not observed at … (more)
Published functional studies demonstrate p.(G321S) results in non-functional channels and significantly reduces KCNQ4 trafficking (Kim et al., 2011; Gao et al., 2013); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 34316018, 28340560, 23399560, 25525159, 31541171, 21951272, 26036578, 9126484, 8035838, 27619418, 18797286, 23776385, 25116015, 23717403, 11556850, 30556268, 27704564, 17033161, 36140355, 12408061, 24616153, 11252765, 28802383, Zhang2021[Review], 26515070, 10369879, 34824372, 34732400, 20966080, 23750663) (less)
|
|
Likely pathogenic
(Apr 11, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Autosomal dominant nonsyndromic hearing loss 2A
Affected status: no
Allele origin:
germline
|
Genome-Nilou Lab
Accession: SCV004173286.1
First in ClinVar: Dec 09, 2023 Last updated: Dec 09, 2023 |
|
|
Pathogenic
(Aug 20, 2015)
|
no assertion criteria provided
Method: literature only
|
Autosomal dominant nonsyndromic hearing loss 2A
Affected status: yes
Allele origin:
germline
|
ClinVar Staff, National Center for Biotechnology Information (NCBI)
Accession: SCV000777820.1
First in ClinVar: May 26, 2018 Last updated: May 26, 2018
Comment:
This variant used to be reported in GeneReviews NBK1209.
|
|
|
Pathogenic
(Nov 22, 2019)
|
no assertion criteria provided
Method: literature only
|
DEAFNESS, AUTOSOMAL DOMINANT 2A
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000026804.3
First in ClinVar: Apr 04, 2013 Last updated: Nov 24, 2019 |
Comment on evidence:
In a Dutch family with autosomal dominant deafness (DFNA2A; 600101), Coucke et al. (1999) identified a 961G-A transition in exon 7 of the KCNQ4 gene, … (more)
In a Dutch family with autosomal dominant deafness (DFNA2A; 600101), Coucke et al. (1999) identified a 961G-A transition in exon 7 of the KCNQ4 gene, which was predicted to produce a gly321-to-ser (G321S) change in the S6 transmembrane domain of the protein. (less)
|
|
Likely pathogenic
(Feb 26, 2019)
|
no assertion criteria provided
Method: case-control
|
Autosomal dominant nonsyndromic hearing loss 2A
Affected status: yes
Allele origin:
inherited
|
Genetic Testing Center for Deafness, Department of Otolaryngology Head & Neck Surgery, Institute of Otolaryngology, Chinese PLA General Hospital
Accession: SCV000902326.1
First in ClinVar: May 12, 2019 Last updated: May 12, 2019 |
Number of individuals with the variant: 1
Clinical Features:
hearing loss (present)
Family history: yes
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Mechanisms of Calmodulin Regulation of Different Isoforms of Kv7.4 K+ Channels. | Sihn CR | The Journal of biological chemistry | 2016 | PMID: 26515070 |
A novel frameshift mutation in KCNQ4 in a family with autosomal recessive non-syndromic hearing loss. | Wasano K | Biochemical and biophysical research communications | 2015 | PMID: 26036578 |
Impaired surface expression and conductance of the KCNQ4 channel lead to sensorineural hearing loss. | Gao Y | Journal of cellular and molecular medicine | 2013 | PMID: 23750663 |
Restoration of ion channel function in deafness-causing KCNQ4 mutants by synthetic channel openers. | Leitner MG | British journal of pharmacology | 2012 | PMID: 21951272 |
Cellular and molecular mechanisms of autosomal dominant form of progressive hearing loss, DFNA2. | Kim HJ | The Journal of biological chemistry | 2011 | PMID: 20966080 |
Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. | Coucke PJ | Human molecular genetics | 1999 | PMID: 10369879 |
Linkage analysis of progressive hearing loss in five extended families maps the DFNA2 gene to a 1.25-Mb region on chromosome 1p. | Van Camp G | Genomics | 1997 | PMID: 9126484 |
Linkage of autosomal dominant hearing loss to the short arm of chromosome 1 in two families. | Coucke P | The New England journal of medicine | 1994 | PMID: 8035838 |
Text-mined citations for rs28939710 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.